AGC Biologics Forms Dedicated "Cell and Gene Technologies Division," Designed to Build Upon Their Track Record of Nine Commercially Approved Products to Date [Yahoo! Finance]
AGC INC UNSP/ADR (ASGLY)
NASDAQ:AMEX Investor Relations:
newsquantified.com/asgly/sec-filings-report/agc-american-depositary-receipts-unsponsored-form-f6-incadr-filed-bank-05ks9e
Company Research
Source: Yahoo! Finance
MILAN & SEATTLE, April 02, 2025 BUSINESS WIRE AGC Biologics , your friendly CDMO expert, today announced the formation of a new Cell and Gene Technologies Division designed to focus and elevate existing AGC Biologics capabilities and further foster the company's performance as the most reliable, experienced and friendly advanced therapy CDMO worldwide. AGC Biologics is investing and growing in a market with substantial capacity but limited scientific capabilities and technically qualified operators. While other cell and gene CDMOs are closing sites and downsizing their workforce, the new AGC Biologics Cell and Gene Technologies Division offers unparalleled support and scientific ability, backed by an abundant global development and manufacturing network in three regions (Milan, Italy; Longmont, CO, USA; Yokohama, Japan). Further, AGC Biologics' proprietary cell therapy and viral vector platforms, including ProntoLVV™ and BravoAAV™, offer developers the ability to increase their spe
Show less
Read more
Impact Snapshot
Event Time:
ASGLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ASGLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ASGLY alerts
High impacting AGC INC UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ASGLY
News
- Chonnam National University Uncovers a New Molecular Target of Obesity [Yahoo! Finance]Yahoo! Finance
- The Lupus Research Alliance Announces Inaugural Mechanistic Clinical Award Recipients to Improve Lupus Understanding, Treatment Options [Yahoo! Finance]Yahoo! Finance
- AGC Biologics to expand cell line development with ATUM partnership [Yahoo! Finance]Yahoo! Finance
- AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line DevelopmentBusiness Wire
- AGC Biologics to Manufacture AAVantgarde's Dual-Vector Gene Therapies for Inherited Retinal Disorders [Yahoo! Finance]Yahoo! Finance